|Dr. Kishor Bhatia to Head National Cancer Institute AIDS Malignancy
The National Cancer Institute (NCI), part of the National Institutes of Health
(NIH), has announced the appointment of Kishor Bhatia, Ph.D., as director of
the new AIDS Malignancy Program (AMP). Bhatia has served as the program director
for the Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis,
since 2004 and his appointment to AMP was effective Oct. 2, 2005.
The AMP is designed to support extramural (research funded by, but not conducted
at, the NCI) HIV and AIDS malignancy research. The AMP will coordinate all AIDS
and AIDS oncology efforts across NCI, including the development of extramural
initiatives and AIDS co-funding agreements. Existing projects that will be managed
by the AMP include the AIDS and Cancer Specimen Resource, the Women’s Interagency
HIV Study, the Multicenter AIDS cohort study, and the AIDS International Training
and research Program. The AMP also will work closely with the Centers for AIDS
Research (CFAR) at the NIH, providing administrative and research support for
AIDS research projects.
Working together, these two programs will emphasize the importance of collaboration
between disciplines and between basic and clinical investigators, research in
which laboratory discoveries are translated into clinical practice, and the importance
of research on prevention and behavioral change. As part of the Cancer Therapy
Evaluation Program within the Division of Cancer Treatment and Diagnosis, Bhatia
will report directly to Mark Clanton, M.D., deputy director for Cancer Delivery
Bhatia worked at the NCI Pediatric Branch from 1989 through 1997 as a senior
staff fellow, and as a senior staff scientist from 1997 through 2000. During
that time he was also an assistant professor at the Uniformed Services University
of Health Sciences in Bethesda, Md. From 1999 through 2004, he served as the
director of the Translational Program in the International Network for Cancer
Treatment and Research at the Institute Louis Pasteur in Brussels, Belgium. He
went on to serve as director of the research center at the Children’s Cancer
Center at King Faisal Hospital in Riyadh, Saudi Arabia, from 2000 to 2004, while
also teaching as an adjunct professor in the Department of Pathology at the University
of Nebraska in Omaha.
Bhatia received a B.S. in microbiology from Pune University in Pune, India.
He later received a Ph.D. in biochemistry from the University of Bombay in Mumbai,
India; he achieved membership in the British Royal College of Pathology in 2003.
In addition to the cellular and molecular biology of cancers related to infectious
disease, Bhatia also is interested in strengthening research networks in developing
countries. He participated in the development of the Middle Eastern Cancer Society
in 1994, and serves as a member of the NIH Working Group on Capacity Building
for International Research.
"We’re very pleased to have Dr. Bhatia at the helm of this new office," said
NCI Director Andrew C. von Eschenbach, M.D. "His work with hematologic cancers
and with research organizations around the globe will be invaluable to the AIDS
For more information about cancer, visit the NCI Web site at http://www.cancer.gov or
call NCI's Cancer Information Service at 1-800-4 CANCER (1-800-422-6237).
The National Institutes of Health (NIH) — The Nation's Medical Research
Agency — includes 27 Institutes and Centers and is a component of
the U. S. Department of Health and Human Services. It is the primary Federal
agency for conducting and supporting basic, clinical, and translational medical
research, and it investigates the causes, treatments, and cures for both common
and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov.